Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.
By M. Maas, P. Nelemans, V. Valentini, P. Das, C. Rödel, L. Kuo, F. Calvo, J. García-Aguilar, R. Glynne-Jones, K. Haustermans and 8 more. The Lancet Oncology, 2010
1,734 citations recorded by the source corpus.
Subfields: Oncology, Pathology and Forensic Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/738efc597121373be37bbdec16062eaa0b63b89d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy (2022, methodology): “For the intention-to-treat organ preservation analysis, patients who had local excision, patients who refused TME, and patients with TME withheld because of distant progression were all censored as having TME.”
- The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges (2019, background): “Approximately 15-27% of locally advanced patients will achieve pCR [166, 167], and studies have shown that these patients do not need surgery [168-170].”
- Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma (2024, unknown): “9 28 29 31 32 10–12 However, it is difficult to predict and assess pathological responses, especially pCR, to neoadjuvant chemoimmunotherapy with high accuracy using non-invasive procedures for now.”